Jak/Stat/SOCS | Cytokines | Deficient mice |
---|---|---|
Jak1 | γccytokines, gp130 cytokines, IL-10, IFN- α , IFN- β , IFN- γ, IL-13 | Neurologic defect (?), mice die perinatally |
Jak2 | Erythropoietin, βccytokines, gp130 cytokines, IL-13, IL-12, GH, prolactin, thrombopoietin, IFN- γ | Embryonically lethal, failed to develop red blood cells |
Jak3 | IL-2, IL-7, IL-15, γc cytokines | SCID |
Tyk2 | gp130 cytokines, IL-13, IL-12, IFN-α, IFN-β, IL-10 | Not yet reported |
Stat1 | IFN- α , IFN- β , IFN- γ , IL-2, IL-6, IL-10 | Susceptibility to viral and some bacterial infections |
 |  | Defective signaling in response to IFNs |
 |  | Impaired tumor rejection |
Stat2 | IFN-α, IFN-β | Defective signaling in response to IFNs* |
Stat3 | LIF, IL-10, IL-6, other gp130 cytokines, γc cytokines, GH | Embryonically lethal |
 |  | Targeted disruption in macrophages and neutrophils showed defective |
 |  | IL-6 and IL-10 signaling |
 |  | Chronic enterocolitis |
 |  | Conditional knockouts showed suppressed epithelial apoptosis and |
 |  | delayed mammary gland involution |
Stat4 | IL-12 | Defective Th1 development |
Stat5a | Prolactin, other γc cytokines, otherβc cytokines, GH, thrombopoietin | Defective lobuloalveolar development in breast |
Stat5b | GH, other γc cytokines,βc cytokines, prolactin, thrombopoietin | Required for sexual dimorphism |
Stat5a/b | GH, IL-2, erythropoietin | Infertile, smaller body size |
 |  | Impaired cell-cycle progression of peripheral T cells |
 |  | Fetal anemia (?) |
Stat6 | IL-4, IL-13 | Defective Th2 development |
Stat4/6 | Â | No Th2 cells in vitro |
SOCS-1 | IFN- γ, IL-6, GH, thrombopoietin, OSM, LIF | Perinatal lethality, hyper-responsiveness to IFN-γ |
SOCS-3 | Erythropoietin, GH, IL-2, leptin, CNTF, IL-11, IL-10 | Embryonic lethality, ? due to erythrocytosis |